SHINE Receives Another Patent
The U.S. Patent and Trademark Office awarded SHINE Medical Technologies a patent that relates to producing medical isotopes, the company announced recently. “This patent protects our technology in America, which…
Category Archives: Biotech
CDI, Nanion Form Agreement
Cellular Dynamics International (CDI) and Nanion Technologies, a leading provider of instrumentation for ion channel drug discovery and screening, announced they have entered into a joint marketing agreement. According to a…
Cellectar, Onconova Therapeutics Collaborate
Cellectar Biosciences announced today it has entered into a strategic collaboration with Onconova Therapeutics, a biopharmaceutical company, to develop new phospholipid drug conjugates (PDC). According to a release, the Newtown,…
Gregor Diagnostics to License Biomarkers
Gregor Diagnostics announced today a licensing agreement for intellectual property with the Wisconsin Alumni Research Foundation. According to a release, the molecular diagnostics company will have exclusive rights to biomarkers that…
Stemina Prepares for Commercialization
Stemina Biomarker Discovery is preparing to go to market in early 2018 with its autism diagnostic test panel, the company announced recently. According to a release, Heiner Dreismann, the former head…
JangoBio Adding Staff, Expanding Testing Capabilities
Story provided by Alex Moe, WisBusiness.com A Madison-based biotech startup with ambitious goals is adding staff and expanding testing capabilities as it seeks early-stage investment. JangoBio is trying to develop…
Propeller, GSK Expand Collaboration
Propeller Health has extended its 2015 collaboration with GlaxoSmithKline (GSK) to improve management of asthma and COPD, the company announced recently. “We are excited to be working closely with GSK…
Cellectar’s Platform Shows Therapeutic Potential
Cellectar Biosciences‘ Phospholipid Drug Conjugate (PDC) research program has generated numerous PDC molecules that show “significant” improved pharmacologic activity, the company announced today. According to a release, Cellectar’s research demonstrates that…
Cellectar Provides Myeloma Study Update
Cellectar Biosciences’ CLR 131 has achieved an overall survival of greater than 22 months in advanced multiple myeloma patients, the company announced today. “We continue to make meaningful progress on…
SHINE Breaks Ground in Janesville
SHINE Medical Technologies broke ground today on Building One, its nuclear technology facility in Janesville, Wis. The 11,500-square-foot facility, located east of Southern Wisconsin Regional Airport, will house a prototype to…
